Unveiling the geroprotective potential of Monarda didyma L.: insights from in vitro studies and a randomized clinical trial on slowing biological aging and improving quality of life
Manuela Campisi,
No information about this author
Luana Cannella,
No information about this author
Omar Paccagnella
No information about this author
et al.
GeroScience,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 10, 2025
Abstract
Aging
is
driven
by
fundamental
mechanisms
like
oxidative
stress,
telomere
shortening
and
changes
in
DNA
methylation,
which
together
prepare
the
ground
for
age-related
diseases.
Botanical
extracts,
rich
bioactive
phytoconstituents,
represent
a
promising
resource
developing
therapies
that
target
these
to
promote
healthy
aging.
This
study
explores
geroprotective
potential
of
Monarda
didyma
L.
extract.
In
vitro
analyses
revealed
extract’s
strong
antioxidant
activity,
ability
reduce
shortening,
capacity
protect
against
damage,
thereby
decreasing
cellular
senescence
improving
endothelial
function.
The
randomized,
double-blind
clinical
trial
demonstrated
daily
oral
supplementation
with
extract
significantly
improved
leukocyte
length
(LTL)
stabilized
methylation
age
(DNAmAge)
intervention
group,
while
placebo
group
experienced
accelerated
epigenetic
aging
hypermethylation
critical
genes
(ELOVL2
FHL2).
also
reported
enhanced
quality
life,
particularly
physical
domain,
along
movement
sleep
indices
detected
questionnaire
wearable
sensors.
These
compelling
findings
position
as
powerful
candidate
future
therapies,
impact
Language: Английский
Exploring the Relationship between Telomere Length and Cognitive Changes in Post-COVID-19 Subjects
Guillermo Efrén Villar-Juárez,
No information about this author
Alma Delia Genis‐Mendoza,
No information about this author
J. Nicolas I. Martínez-López
No information about this author
et al.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(10), P. 2296 - 2296
Published: Oct. 10, 2024
Background/Objectives:
Emerging
evidence
suggests
that
patients
suffering
from
COVID-19
may
experience
neurocognitive
symptoms.
Furthermore,
other
studies
indicate
a
probable
association
between
leukocyte
telomere
length
(LTL)
and
changes
in
subjects
with
post-COVID-19
condition.
Our
study
was
designed
to
determine
the
correlation
cognitive
subjects.
Methods:
This
included
256
subjects,
categorized
based
on
SARS-CoV-2
infection
2020
2023.
In
addition,
psychiatric
diagnosis
were
considered.
Moreover,
MoCA
MMSE
scales
applied.
Telomere
determined
using
polymerase
chain
reaction,
statistical
analysis
employed
ANOVA
X2
tests.
Results:
We
identified
decrease
LTL
individuals
conditions
compared
those
without
(p
≤
0.05).
However,
no
found
impairment
post-COVID-19.
Conclusions:
The
findings
suggest
is
affected
by
infection.
Nonetheless,
this
important
finding
requires
further
research
monitoring
neurological
post-COVID
Language: Английский